Patient Adherence Infographic

Alan Davies quote
Down

Cost of non-adherence by patients

1. See below for source

“America's other drug problem”

National Council on Patient Information and Education (NCPIE)

“Drugs don't work on patients who don't take them”

C. Everett Koop, MD

For every 100 prescriptions written

2. See below for source

Down

Five dimensions of adherence

3. See below for source

Down

Types of non-adherence

Non-fulfillment

Prescription is never filled or initiated.

Non-persistence

Patients stop taking medication after taking it. Rarely intentional - usually arises from miscommunication or resource / capacity limitations.

Non-conforming

Medication is not taken as prescribed. Missed doses, incorrect doses, dose taken at wrong time.

4. See below for source

Down

Frequency of adverse drug events (ADEs)

 

5. See below for source

Down

Barriers to great outcomes

  • Treatment
  • Adherence
  • Outcomes
Down

Patient centred, team-based care

6. See below for source

Down

Three pillars of improved adherence

Appropriate medication use

Improve
drug
regimen

Reduce
cost
barriers

Essentra logo

Address
patient
behaviour

Essentra's packaging solutions are designed to improve patient adherence by addressing issues like ease of use and understanding. Including:

  • Follow up
  • Engage patients in the care process
  • Address patient preferences, limitations and priorities
  • Educate patients about their condition, how and why to take medications

Essentra making a difference

7. See below for source

Down

Think inside the box

 

Source

  1. 5 trends changing drug adherence for the better – Lisa LaMotta – BioP – May 2017; Health Secretary – Jeremy Hunt – Medication Adherence Statement – July 2015; Network for Excellence in Health Innovation – 2009
  2. National Association of Chain Drug Stores, Pharmacies: Improving Health, Reducing Costs, July 2010. Based on IMS health data
  3. World Health Organisation, 2003
  4. Jimmy, Beena and Jimmy Jose. "Patient Medication Adherence: Measures in Daily Practice" Oman Medical Journal, May 2011, 155-159
  5. Shehab N et al. JAMA 2016; 316:2115-25 Budnitz DS et al. JAMA 2006; 296:1858-66 Bourgeois FT et al. Phamacoepidemiol Drug Saf 2010; 19:901-10
  6. Dr. Rajiv Shah, The New Disrupters in Healthcare https://www.youtube.com/watch?v=ajmT93H2RpA
  7. Avalere Health, NEHI Analysis